Pnc Financial Services Group, Inc. Rocket Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 22,455 shares of RCKT stock, worth $187,499. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,455
Previous 16,113
39.36%
Holding current value
$187,499
Previous $297,000
5.05%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding RCKT
# of Institutions
244Shares Held
108MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$148 Million3.63% of portfolio
-
Wellington Management Group LLP Boston, MA14MShares$117 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$54.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$51.7 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$43.4 Million1.26% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $632M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...